Jason Pitofsky - 04 Nov 2026 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Nov 2026, 16:01:47 UTC
Prior SEC filing
11 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Pitofsky
Filing notes and source

Key filing fact

Jason Pitofsky filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 06 Nov 2026.

Key facts

  • This page summarizes Jason Pitofsky's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
  • 14 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2026, 16:01.

Change

  • Previous filing in this sequence was filed on 11 Feb 2026.
  • Current net transaction value: -$3,827,159.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002009236 Primary reporting owner

Pitofsky Jason

Relationship
SVP Controller
Address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN
Signature
/s/ Jason Pitofsky
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,500
Change %
+35%
Price
$726.53*
Shares after
5,772
Date
04 Nov 2026
Ownership
Direct
REGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,478
Change %
+26%
Price
$644.54*
Shares after
7,250
Date
04 Nov 2026
Ownership
Direct
REGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+905
Change %
+12%
Price
$492.00*
Shares after
8,155
Date
04 Nov 2026
Ownership
Direct
REGN transaction

Common Stock

Sale

Transaction value
-$412,471
Shares
-439
Change %
-5.4%
Price
$939.57
Shares after
7,716
Date
04 Nov 2026
Ownership
Direct
Footnotes
F1
REGN transaction

Common Stock

Sale

Transaction value
-$540,764
Shares
-575
Change %
-7.5%
Price
$940.46
Shares after
7,141
Date
04 Nov 2026
Ownership
Direct
Footnotes
F2
REGN transaction

Common Stock

Sale

Transaction value
-$924,632
Shares
-982
Change %
-14%
Price
$941.58
Shares after
6,159
Date
04 Nov 2026
Ownership
Direct
Footnotes
F3
REGN transaction

Common Stock

Sale

Transaction value
-$1,144,907
Shares
-1,215
Change %
-20%
Price
$942.31
Shares after
4,944
Date
04 Nov 2026
Ownership
Direct
Footnotes
F4
REGN transaction

Common Stock

Sale

Transaction value
-$499,127
Shares
-529
Change %
-11%
Price
$943.53
Shares after
4,415
Date
04 Nov 2026
Ownership
Direct
Footnotes
F5
REGN transaction

Common Stock

Sale

Transaction value
-$101,976
Shares
-108
Change %
-2.4%
Price
$944.22
Shares after
4,307
Date
04 Nov 2026
Ownership
Direct
Footnotes
F6
REGN transaction

Common Stock

Sale

Transaction value
-$33,096
Shares
-35
Change %
-0.81%
Price
$945.61
Shares after
4,272
Date
04 Nov 2026
Ownership
Direct
REGN transaction

Common Stock

Sale

Transaction value
-$170,186
Shares
-179
Change %
-100%
Price
$950.76
Shares after
0
Date
04 Nov 2026
Ownership
by Spouse
Footnotes
F7
REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
48
Date
04 Nov 2026
Ownership
By 401(k) Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-905
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
905
Exercise price
$492.00
Footnotes
F8
REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-1,478
Change %
-75%
Price
$0.000000*
Shares after
500
Date
04 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,478
Exercise price
$644.54
Footnotes
F8
REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-1,500
Change %
-38%
Price
$0.000000*
Shares after
2,478
Date
04 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,500
Exercise price
$726.53
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents volume-weighted average price of sales of 439 shares of Company stock on November 4, 2026 at prices ranging from $939.10 to $939.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F2

Represents volume-weighted average price of sales of 575 shares of Company stock on November 4, 2026 at prices ranging from $940.15 to $940.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F3

Represents volume-weighted average price of sales of 982 shares of Company stock on November 4, 2026 at prices ranging from $941.08 to $941.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F4

Represents volume-weighted average price of sales of 1,215 shares of Company stock on November 4, 2026 at prices ranging from $942.00 to $942.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F5

Represents volume-weighted average price of sales of 529 shares of Company stock on November 4, 2026 at prices ranging from $943.00 to $943.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F6

Represents volume-weighted average price of sales of 108 shares of Company stock on November 4, 2026 at prices ranging from $944.00 to $944.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F7

Represents volume-weighted average price of sales of 179 shares of Company stock on November 4, 2026 at prices ranging from $950.45 to $950.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.

Footnote F8

The stock option award vested in four equal annual installments, commencing one year after the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .